Search Results 111-120 of 1331 for ☃휴대폰소액결제현금화 (010-9675-8884) 카톡 ON8884 콘텐츠이용료소액결제☃

  1. Excessive Smartphone Use in Anxiety Disorder - Mayo Clinic

    The Primary objective of this study is to whether excessive use of smartphone apps, especially those related to social media has a detrimental effect on an ...

  2. Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of Sulfonamide Allergy - Mayo Clinic

    Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

  3. Study of ASTX727 vs IV Decitabine in MDS and CMML - Mayo Clinic

    After completion of PK studies during the first 2 treatment cycles, subjects will continue to receive treatment with ASTX727 from Cycle 3 onward (in 28-day ...

  4. Evaluation of PCLs Using Three EUS-FNA Needles - Mayo Clinic

    About this study. To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to ...

  5. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    The study includes a dose escalation phase to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) and an expansion phase to ...

  6. A Study to Evaluate the Burden of Treatment and Illness in Advanced Heart Failure Patients - Mayo Clinic

    The primary purpose of this study is to identify which aspects of treatment are most prevalent and burdensome to patients with advanced heart failure.

  7. The WEB-IT Clinical Study

    About this study. The purpose of this study is to determine the safety and effectiveness of the WEB Aneurysm Embolization System for the treatment of WNBAs ...

  8. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  9. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

  10. GS-4997 in Adults With Pulmonary Arterial Hypertension - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...